919 results on '"Possinger, K."'
Search Results
2. Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma
3. Metastatic breast cancer: are we treating the same patients as in the past?
4. Mammakarzinom der Frau
5. Neue antineoplastische Substanzen und ihre klinische Entwicklung
6. Paraneoplasien
7. Hyperkalzämie
8. Therapy Regimens Used in Adjuvant and Neoadjuvant Treatment of the Discussed Tumor Types
9. Mammakarzinom
10. Pankreaskarzinom
11. Hochmaligne Non-Hodgkin-Lymphome (NHL)
12. Paraneoplastische Syndrome
13. Die Apoptose humaner neutrophiler Granulozyten ist assoziiert mit einer erhöhten Expression der Tetraspanine CD53 and CD63
14. Mammakarzinom der Frau
15. A comparison of international breast cancer guidelines – Do the national guidelines differ in treatment recommendations?
16. Mammakarzinom der Frau
17. Hyperkalzämie
18. Paraneoplastische Syndrome
19. On the Validation of Classification Trees
20. Mammakarzinom
21. Bisphosphonate
22. Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors
23. Mammakarzinom: Adjuvante Hormon- und Chemotherapie
24. Third consensus on medical treatment of metastatic breast cancer
25. Metastasiertes Mammakarzinom: Differenzierte, möglichst zielgerichtete medikamentöse Therapie
26. Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer
27. Aktuelle Veränderungen der S3-Leitlinie Mammakarzinom: Adjuvante Systemtherapie
28. High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS?
29. Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up
30. A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
31. Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model
32. Overall survival in advanced breast cancer is associated with the type of 1st line treatment but not with an objective response to this treatment: ID 442
33. Baseline results from ACT-FASTER, a prospective cohort study exploring treatmentpatterns with fulvestrant and exemestane in postmenopausal patients with advancedhormone-receptor positive breast cancer under real-life conditions in Germany: ID 120
34. Mammakarzinom bei alten Patientinnen: Stellenwert der adjuvanten Chemotherapie und Radiotherapie
35. Therapie des Mammakarzinoms: Vom Hormon bis zum Antikörper
36. Orbital metastases in breast cancer: report of two cases and review of the literature
37. Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study
38. Proteasom-Inhibitoren
39. Upregulation of HER-2/neu by Ovarian Ablation: Results of a Randomized Trial Comparing Leuprorelin to CMF as Adjuvant Therapy in Node-positive Breast Cancer Patients
40. PPARγ Ligands and ATRA Inhibit the Invasion of Human Breast Cancer Cells in vitro
41. Novel Therapeutic Approach: Ligands for PPARγ and Retinoid Receptors Induce Apoptosis in bcl-2-positive Human Breast Cancer Cells
42. Adjuvante und neoadjuvante systemische Therapie des Mammakarzinoms
43. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum β2-microglobulin levels in patients with multiple myeloma
44. Der Stellenwert der Aromatasehemmer in der Behandlung des Mammakarzinoms: Eine kritische Gegenüberstellung pharmakologischer und klinischer Fakten
45. Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuria
46. Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation
47. Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma
48. Disseminated Mucormycosis Caused by Absidia corymbifera Leading to Cerebral Vasculitis
49. Neue Substanzen zur Therapie des Mammakarzinoms: Standards auf dem Prüfstand
50. Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.